Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Shagufta Naz, Lina Tariq Al Kury, Humaira Nadeem, Fawad Ali Shah, Aman Ullah, Rehan Zafar Paracha, Muhammad Imran & Shupeng Li. (2022) Synthesis, In Silico and Pharmacological Evaluation of New Thiazolidine-4-Carboxylic Acid Derivatives Against Ethanol-Induced Neurodegeneration and Memory Impairment. Journal of Inflammation Research 15, pages 3643-3660.
Read now
Read now
Sheunopa C. Mzezewa, Sylvester I. Omoruyi, Luke S. Zondagh, Sarel F. Malan, Okobi E. Ekpo & Jacques Joubert. (2021) Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer’s disease agents. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1606-1620.
Read now
Read now
Daniela Secci, Simone Carradori, Anél Petzer, Paolo Guglielmi, Melissa D’Ascenzio, Paola Chimenti, Donatella Bagetta, Stefano Alcaro, Gokhan Zengin, Jacobus P. Petzer & Francesco Ortuso. (2019) 4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 597-612.
Read now
Read now
Vincenza Andrisano, Marina Naldi, Angela De Simone & Manuela Bartolini. (2018) A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017. Expert Opinion on Therapeutic Patents 28:6, pages 455-465.
Read now
Read now
Cornelis J Van der Schyf. (2015) Rational drug discovery design approaches for treating Parkinson’s disease. Expert Opinion on Drug Discovery 10:7, pages 713-741.
Read now
Read now
Laura Friggeri, Daniela De Vita, Fabiana Pandolfi, Silvano Tortorella, Roberta Costi, Roberto Di Santo & Luigi Scipione. (2015) Design, synthesis and evaluation of 3,4-dihydroxybenzoic acid derivatives as antioxidants, bio-metal chelating agents and acetylcholinesterase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 30:1, pages 166-172.
Read now
Read now
Yanier Nuñez Figueredo, Estael Ochoa Rodríguez, Yamila Verdecia Reyes, Carmen Carrillo Domínguez, Alicia Lagarto Parra, Jeney Ramirez Sánchez, René Delgado Hernández, Marlene Porto Verdecia & Gilberto L Pardo Andreu. (2013) Characterization of the anxiolytic and sedative profile of JM-20: a novel benzodiazepine–dihydropyridine hybrid molecule. Neurological Research 35:8, pages 804-812.
Read now
Read now
Athan Spiros & Hugo Geerts. (2012) A quantitative way to estimate clinical off-target effects for human membrane brain targets in CNS research and development. Journal of Experimental Pharmacology 4, pages 53-61.
Read now
Read now
Alexandre V Ivachtchenko & Yan A Ivanenkov. (2012) 5HT6 receptor antagonists: a patent update. Part 1. Sulfonyl derivatives. Expert Opinion on Therapeutic Patents 22:8, pages 917-964.
Read now
Read now
Ansgar Brüning. (2011) Targeting the off-targets: a computational bioinformatics approach to understanding the polypharmacology of nelfinavir. Expert Review of Clinical Pharmacology 4:5, pages 571-573.
Read now
Read now
Articles from other publishers (55)
Sarmistha Mitra, Raju Dash, Amena Al Nishan, Sarmin Ummey Habiba & Il Soo Moon. (2023) Brain modulation by the gut microbiota: From disease to therapy. Journal of Advanced Research 53, pages 153-173.
Crossref
Crossref
Ute Laermann-Nguyen. (2023) Determinants of R&D Project Abandonment: Evidence from the Pharmaceutical Industry. SSRN Electronic Journal.
Crossref
Crossref
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, How Wan Leong, Yew Mun Chan, Zhi Ling Chan & Ethan Wei Jie Kong. (2022) Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease. Pharmaceuticals 15:12, pages 1560.
Crossref
Crossref
Olga Kopach, Dmitri A. Rusakov & Sergiy Sylantyev. (2022) Multi-target action of β-alanine protects cerebellar tissue from ischemic damage. Cell Death & Disease 13:8.
Crossref
Crossref
Narayanaperumal Pravin & Krzysztof Jozwiak. (2022) Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer’s Diseases: Emerging Paradigms and Strategies. International Journal of Molecular Sciences 23:11, pages 6085.
Crossref
Crossref
Ehsanifar M & Montazeri Z. (2022) Neuroprotective Effects of Thiazolidine-4-Carboxylic Acid Derivatives on Memory Impairment and Neurodegeneration. Journal of Biomedical Research & Environmental Sciences 3:2, pages 210-214.
Crossref
Crossref
Yasmeen T. AlNajjar, Moustafa Gabr, Ahmed K. ElHady, Mohamed Salah, Gerrit Wilms, Ashraf H. Abadi, Walter Becker, Mohammad Abdel-Halim & Matthias Engel. (2022) Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects. European Journal of Medicinal Chemistry 227, pages 113911.
Crossref
Crossref
Anshul Tiwari & Sakshi Singh. 2022. Bioinformatics. Bioinformatics
207
217
.
Rita Bernadett Vlocskó, Sinem Apaydın, Béla Török & Marianna Török. 2022. Contemporary Chemical Approaches for Green and Sustainable Drugs. Contemporary Chemical Approaches for Green and Sustainable Drugs
457
492
.
Vanesa Nozal, Alfonso García‐Rubia, Eva P. Cuevas, Concepción Pérez, Carlota Tosat‐Bitrián, Fernando Bartolomé, Eva Carro, David Ramírez, Valle Palomo & Ana Martínez. (2021) From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis. Angewandte Chemie International Edition 60:35, pages 19344-19354.
Crossref
Crossref
Vanesa Nozal, Alfonso García‐Rubia, Eva P. Cuevas, Concepción Pérez, Carlota Tosat‐Bitrián, Fernando Bartolomé, Eva Carro, David Ramírez, Valle Palomo & Ana Martínez. (2021) From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis. Angewandte Chemie 133:35, pages 19493-19503.
Crossref
Crossref
Nashmin Fayazi, Mohsen Sheykhhasan, Sara Soleimani Asl & Rezvan Najafi. (2021) Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease Treatment. Molecular Neurobiology 58:7, pages 3494-3514.
Crossref
Crossref
Oliwia Koszła, Piotr Stępnicki, Agata Zięba, Angelika Grudzińska, Dariusz Matosiuk & Agnieszka A. Kaczor. (2021) Current Approaches and Tools Used in Drug Development against Parkinson’s Disease. Biomolecules 11:6, pages 897.
Crossref
Crossref
Tanay Dalvi, Bhaskar Dewangan, Gopal Agarwal, Dattatray Shinde Suchita, Alok Jain, Akshay Srivastava & Bichismita Sahu. (2021) Design, synthesis and in-vitro evaluation of fluorinated triazoles as multi-target directed ligands for Alzheimer disease. Bioorganic & Medicinal Chemistry Letters 42, pages 127999.
Crossref
Crossref
Raju Dash, Israt Jahan, Md. Chayan Ali, Sarmistha Mitra, Yeasmin Akter Munni, Binod Timalsina, Md. Abdul Hannan & Il Soo Moon. (2021) Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases. Neurochemistry International 145, pages 105011.
Crossref
Crossref
Ádám Sipos, Eszter Szennyes, Nikolett Éva Hajnal, Sándor Kun, Katalin E. Szabó, Karen Uray, László Somsák, Tibor Docsa & Éva Bokor. (2021) Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors. Pharmaceuticals 14:4, pages 364.
Crossref
Crossref
Martina Kaniakova, Jan Korabecny, Kristina Holubova, Lenka Kleteckova, Marketa Chvojkova, Kristina Hakenova, Lukas Prchal, Martin Novak, Rafael Dolezal, Vendula Hepnarova, Barbora Svobodova, Tomas Kucera, Katarina Lichnerova, Barbora Krausova, Martin Horak, Karel Vales & Ondrej Soukup. (2021) 7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo. Biochemical Pharmacology 186, pages 114460.
Crossref
Crossref
Dharmendra Kumar Khatri, Amey Kadbhane, Monica Patel, Shweta Nene, Srividya Atmakuri, Saurabh Srivastava & Shashi Bala Singh. (2021) Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders. Current Research in Pharmacology and Drug Discovery 2, pages 100022.
Crossref
Crossref
Nupur Shrivastava, Ankit Parikh, Aiswarya Chaudhuri, Javed Ali, Sanjula Baboota & Sanjay Garg. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs
259
305
.
Badrinathan Sridharan & Meng-Jen Lee. 2021. Medicinal Herbs and Fungi. Medicinal Herbs and Fungi
79
112
.
Fabio Pammolli, Lorenzo Righetto, Sergio Abrignani, Luca Pani, Pier Giuseppe Pelicci & Emanuele Rabosio. (2020) The endless frontier? The recent increase of R&D productivity in pharmaceuticals. Journal of Translational Medicine 18:1.
Crossref
Crossref
Zuha Imtiyaz, Yi-Tzu Lin, Ut-Hang Cheong, Alagie Jassey, Hui-Kang Liu & Mei-Hsien Lee. (2020) Compounds isolated from Euonymus spraguei Hayata induce ossification through multiple pathways. Saudi Journal of Biological Sciences 27:9, pages 2227-2237.
Crossref
Crossref
Hui-Ju Tseng, Mei-Hsiang Lin, Young-Ji Shiao, Ying-Chen Yang, Jung-Chun Chu, Chun-Yung Chen, Yi-Ying Chen, Tony Eight Lin, Chih-Jou Su, Shiow-Lin Pan, Liang-Chieh Chen, Chen-Yu Wang, Kai-Cheng Hsu & Wei-Jan Huang. (2020) Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer’s disease. European Journal of Medicinal Chemistry 192, pages 112193.
Crossref
Crossref
Juan Francisco Sánchez-Tejeda, Juan F. Sánchez-Ruiz, Juan Rodrigo Salazar & Marco A. Loza-Mejía. (2020) A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis. Frontiers in Chemistry 8.
Crossref
Crossref
Rohan Gupta, Rashmi K. Ambasta & Pravir Kumar. (2020) Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders. Life Sciences 243, pages 117278.
Crossref
Crossref
Marcella Catania, Giorgio Giaccone, Mario Salmona, Fabrizio Tagliavini & Giuseppe Di Fede. (2019) Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Bijo Mathew, Della G. T. Parambi, Githa E. Mathew, Md. Sahab Uddin, Sini T. Inasu, Hoon Kim, Akash Marathakam, Mazhuvancherry Kesavan Unnikrishnan & Simone Carradori. (2019) Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases. Archiv der Pharmazie 352:11, pages 1900177.
Crossref
Crossref
Junting Zhou, Xueyang Jiang, Siyu He, Hongli Jiang, Feng Feng, Wenyuan Liu, Wei Qu & Haopeng Sun. (2019) Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms. Journal of Medicinal Chemistry 62:20, pages 8881-8914.
Crossref
Crossref
Siew L. Cheong, Stephanie Federico, Giampiero Spalluto, Karl-Norbert Klotz & Giorgia Pastorin. (2019) The current status of pharmacotherapy for the treatment of Parkinson’s disease: transition from single-target to multitarget therapy. Drug Discovery Today 24:9, pages 1769-1783.
Crossref
Crossref
Guilherme Martins Silva, Mariana Pegrucci Barcelos, João Gabriel Curtolo Poiani, Lorane Izabel da Silva Hage‐Melim & Carlos Henrique Tomich de Paula da Silva. (2019) Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review. ChemMedChem 14:16, pages 1467-1483.
Crossref
Crossref
Agnieszka Basta-Kaim, Joanna Ślusarczyk, Krzysztof Szczepanowicz, Piotr Warszyński, Monika Leśkiewicz, Magdalena Regulska, Ewa Trojan & Władysław Lasoń. (2019) Protective effects of polydatin in free and nanocapsulated form on changes caused by lipopolysaccharide in hippocampal organotypic cultures. Pharmacological Reports 71:4, pages 603-613.
Crossref
Crossref
Balasubramanian Lakshminarayanan, Seung Cheol Baek, Jae Pil Lee, Nagappan Kannappan, Giuseppe Felice Mangiatordi, Orazio Nicolotti, Thillainayagam Subburaju, Hoon Kim & Bijo Mathew. (2019) Ethoxylated Head of Chalcones as a New Class of Multi‐Targeted MAO Inhibitors. ChemistrySelect 4:21, pages 6614-6619.
Crossref
Crossref
Dalinda Isabel Sánchez-Vidaña, Jason Ka Wing Chow, Sheng Quan Hu, Benson Wui Man Lau & Yi-Fan Han. (2019) Molecular Targets of Bis (7)-Cognitin and Its Relevance in Neurological Disorders: A Systematic Review. Frontiers in Neuroscience 13.
Crossref
Crossref
Si‐Yuen Lee, Julian H. George, David A. Nagel, Hua Ye, Gray Kueberuwa & Leonard W. Seymour. (2019) Optogenetic control of iPS cell‐derived neurons in 2D and 3D culture systems using channelrhodopsin‐2 expression driven by the synapsin‐1 and calcium‐calmodulin kinase II promoters. Journal of Tissue Engineering and Regenerative Medicine 13:3, pages 369-384.
Crossref
Crossref
Tomáš Bříza, Jarmila Králová, Silvie Rimpelová, Martin Havlík, Robert Kaplánek, Zdeněk Kejík, Pavel Martásek, Ivan Mikula, Petr Džubák, Marián Hajdúch, Tomáš Ruml & Vladimír Král. (2019) Pentamethinium salts as ligands for cancer: Sulfated polysaccharide co-receptors as possible therapeutic target. Bioorganic Chemistry 82, pages 74-85.
Crossref
Crossref
Nalini Schaduangrat, Nuttapat Anuwongcharoen, Chuleeporn Phanus-umporn, Nagaya Sriwanichpoom, Jarl E.S. Wikberg & Chanin Nantasenamat. 2019. In Silico Drug Design. In Silico Drug Design
281
302
.
William R. Swindell, Krzysztof Bojanowski, Mark S. Kindy, Raymond M. W. Chau & Dorothy Ko. (2018) GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis. Translational Neurodegeneration 7:1.
Crossref
Crossref
Olga Lage, María Ramos, Rita Calisto, Eduarda Almeida, Vitor Vasconcelos & Francisca Vicente. (2018) Current Screening Methodologies in Drug Discovery for Selected Human Diseases. Marine Drugs 16:8, pages 279.
Crossref
Crossref
Yanier Nuñez-Figueredo, Jeney Ramírez-Sánchez, Gilberto L. Pardo Andreu, Estael Ochoa-Rodríguez, Yamila Verdecia-Reyes & Diogo O. Souza. (2018) Multi-targeting effects of a new synthetic molecule (JM-20) in experimental models of cerebral ischemia. Pharmacological Reports 70:4, pages 699-704.
Crossref
Crossref
Tyler Joseph Wenzel & Andis Klegeris. (2018) Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease. Life Sciences 207, pages 314-322.
Crossref
Crossref
Hossein Pakdaman, Koroush Gharagozli, Mehdi Abbasi, Ali Sobhanian, Ali Bakhshandehpour, Farzad Ashrafi, Mitra Khalilzad & Ali Amini Harandi. (2018) Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study. Dementia and Geriatric Cognitive Disorders Extra 8:1, pages 174-179.
Crossref
Crossref
Lilian A. Patrón & Paul R. August. (2018) Modeling neuromuscular junctions <em>in vitro</em>: A review of the current progress employing human induced pluripotent stem cells. AIMS Cell and Tissue Engineering 2:2, pages 91-118.
Crossref
Crossref
Abhilash Jayaraj, Ruchika Bhat, Amita Pathak, Manpreet Singh & B. Jayaram. 2019. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. Multi-Target Drug Design Using Chem-Bioinformatic Approaches
487
504
.
Amit Kumar Halder, Ana S. Moura & M. Natália D. S. Cordeiro. 2019. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. Multi-Target Drug Design Using Chem-Bioinformatic Approaches
155
186
.
George N. Pairas, Fereniki Perperopoulou, Petros G. Tsoungas & George Varvounis. (2017)
The Isoxazole Ring and Its
N
-Oxide: A Privileged Core Structure in Neuropsychiatric Therapeutics
. ChemMedChem 12:6, pages 408-419.
Crossref
Crossref
Cornelis J. Van der Schyf. (2016) Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases. Drug Development Research 77:8, pages 458-468.
Crossref
Crossref
Lois-May Young, Werner J. Geldenhuys, Olwen C. Domingo, Sarel F. Malan & Cornelis J. Van der Schyf. (2016) Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers. Archiv der Pharmazie 349:4, pages 252-267.
Crossref
Crossref
Manish K. Gupta, Swati Gupta & Ravindra K. Rawal. 2016. Artificial Neural Network for Drug Design, Delivery and Disposition. Artificial Neural Network for Drug Design, Delivery and Disposition
153
179
.
Yanier Nuñez-Figueredo, Jeney Ramírez-Sánchez, Gisele Hansel, Elisa Nicoloso Simões Pires, Nelson Merino, Odalys Valdes, René Delgado-Hernández, Alicia Lagarto Parra, Estael Ochoa-Rodríguez, Yamila Verdecia-Reyes, Christianne Salbego, Silvia L. Costa, Diogo O. Souza & Gilberto L. Pardo-Andreu. (2014) A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo. Neuropharmacology 85, pages 517-527.
Crossref
Crossref
Yanier Nuñez-Figueredo, Jeney Ramírez-Sánchez, René Delgado-Hernández, Marlene Porto-Verdecia, Estael Ochoa-Rodríguez, Yamila Verdecia-Reyes, Javier Marin-Prida, Michael González-Durruthy, Sergio A. Uyemura, Fernando P. Rodrigues, Carlos Curti, Diogo O. Souza & Gilberto L. Pardo-Andreu. (2014) JM-20, a novel benzodiazepine–dihydropyridine hybrid molecule, protects mitochondria and prevents ischemic insult-mediated neural cell death in vitro. European Journal of Pharmacology 726, pages 57-65.
Crossref
Crossref
Aurelie BornotUdo Bauer, Alastair BrownMike FirthCaroline HellawellOla Engkvist. (2013) Systematic Exploration of Dual-Acting Modulators from a Combined Medicinal Chemistry and Biology Perspective. Journal of Medicinal Chemistry 56:3, pages 1197-1210.
Crossref
Crossref
Laura L. Hurley & Yousef Tizabi. (2012) Neuroinflammation, Neurodegeneration, and Depression. Neurotoxicity Research 23:2, pages 131-144.
Crossref
Crossref
J.A. Lockman, W.J. Geldenhuys, M.R. Jones-Higgins, J.D. Patrick, D.D. Allen & C.J. Van der Schyf. (2012) NGP1-01, a multi-targeted polycyclic cage amine, attenuates brain endothelial cell death in iron overload conditions. Brain Research 1489, pages 133-139.
Crossref
Crossref
Maria Laura Bolognesi, Carlo Melchiorre, Cornelis J. Van der Schyf & Moussa Youdim. 2012. Designing Multi-Target Drugs. Designing Multi-Target Drugs
290
315
.
Werner J. Geldenhuys, Moussa B.H. Youdim, Richard T. Carroll & Cornelis J. Van der Schyf. (2011) The emergence of designed multiple ligands for neurodegenerative disorders. Progress in Neurobiology 94:4, pages 347-359.
Crossref
Crossref